MetLife (NYSE: MET) files Form 144 showing proposed sales of 562 and 725 shares

Rhea-AI Filing Summary

MetLife reported proposed sales of Common Stock under Form 144. The filing lists a sale of 562 shares on 01/09/2026 with a value of $44,628.42 and a sale of 725 shares on 03/02/2026 with a value of $53,099. The securities are Common Stock traded on the NYSE; a broker address for Barclays is shown.

Insights

Equity Compliance Specialist

Form 144 notice lists two planned dispositions of Common Stock by MetLife-related accounts.

The filing shows proposed dispositions of 562 shares on 01/09/2026 and 725 shares on 03/02/2026

These are routine Rule 144-style notices for resale by holders; the excerpt names brokerage details and plan/trust account labels. Cash-flow treatment and ultimate settlement instructions are not detailed in the excerpt.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Barclays 745 Seventh Ave New York NY 10019	8	548.88	652053867	03/20/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	10/11/2021	Purchase	Citigroup Global Markets			8	10/13/2021	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Separate Account SPI 1 Metlife Way Whippany NJ 07981	Common Stock	01/09/2026	562	44628.42
MetLife 401k Plan Trust-Large Cap Equity Index 1 Metlife Way Whippany NJ 07981	Common Stock	03/02/2026	725	53099

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What sales does MetLife (MET) disclose on this Form 144?

The filing discloses proposed sales of 562 shares and 725 shares. The entries show a 01/09/2026 trade for $44,628.42 and a 03/02/2026 trade for $53,099, respectively.

Which accounts are associated with the Form 144 transactions for MET?

The excerpt lists plan and separate account labels, including a MetLife 401k Plan Trust and a Separate Account. These account names appear next to the listed share quantities and values.

On which exchange and through which broker are the securities listed?

The Common Stock is listed on the NYSE. The filing shows a Barclays address at 745 Seventh Ave, New York as a broker-related entry in the securities section.

Does the Form 144 excerpt state proceeds or cash-flow recipients?

The excerpt shows dollar figures next to each sale line ($44,628.42 and $53,099), but it does not explicitly state who receives proceeds or the final cash‑flow treatment.

Are there prior purchase details noted in the filing for MET shares?

Yes; the excerpt includes an earlier purchase line dated 10/13/2021 through Citigroup Global Markets and references an original purchase date of 10/11/2021 in the securities section.